Literature DB >> 16151907

Molecular defects in Sanfilippo syndrome type B (mucopolysaccharidosis IIIB).

C E Beesley1, M Jackson, E P Young, A Vellodi, B G Winchester.   

Abstract

Sanfilippo syndrome type B (mucopolysaccharidosis IIIB) is an autosomal recessive disease that is caused by the deficiency of the lysosomal enzyme alpha-N-acetylglucosaminidase (NAGLU). NAGLU is involved in the degradation of the glycosaminoglycan (GAG) heparan sulphate, and a deficiency results in the accumulation of partially degraded GAGs inside lysosomes. Early clinical symptoms include hyperactivity, aggressiveness and delayed development, followed by progressive mental deterioration, although there are a small number of late-onset attenuated cases. The gene for NAGLU has been fully characterized and we report the molecular analysis of 18 Sanfilippo B families. In total, 34 of the 36 mutant alleles were characterized in this study and 20 different mutations were identified including 8 novel changes (R38W, V77G, 407-410del4, 703delT, A246P, Y335C, 1487delT, E639X). The four novel missense mutations were transiently expressed in Chinese hamster ovary cells and all were shown to decrease the NAGLU activity markedly, although A246P did produce 12.7% residual enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16151907     DOI: 10.1007/s10545-005-0093-y

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  29 in total

1.  Allelic heterogeneity in Spanish patients with Sanfilippo disease type B. Identification of eight new mutations.

Authors:  M J Coll; C Antón; A Chabás
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Localisation of a gene for mucopolysaccharidosis IIIC to the pericentromeric region of chromosome 8.

Authors:  J Ausseil; J C Loredo-Osti; A Verner; C Darmond-Zwaig; I Maire; B Poorthuis; O P van Diggelen; T J Hudson; T M Fujiwara; K Morgan; A V Pshezhetsky
Journal:  J Med Genet       Date:  2004-12       Impact factor: 6.318

3.  Expression and characterization of human recombinant and alpha-N-acetylglucosaminidase.

Authors:  B Weber; J J Hopwood; G Yogalingam
Journal:  Protein Expr Purif       Date:  2001-03       Impact factor: 1.650

4.  Modification of enzymatically amplified DNA for the detection of point mutations.

Authors:  A Haliassos; J C Chomel; L Tesson; M Baudis; J Kruh; J C Kaplan; A Kitzis
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

5.  Sanfilippo syndrome in Turkey: Identification of novel mutations in subtypes A and B.

Authors:  Serap Emre; Mugen Terzioglu; Aysegul Tokatli; Turgay Coskun; Imran Ozalp; Birgit Weber; John J Hopwood
Journal:  Hum Mutat       Date:  2002-02       Impact factor: 4.878

6.  Dimethylmethylene blue-based spectrophotometry of glycosaminoglycans in untreated urine: a rapid screening procedure for mucopolysaccharidoses.

Authors:  J G de Jong; R A Wevers; C Laarakkers; B J Poorthuis
Journal:  Clin Chem       Date:  1989-07       Impact factor: 8.327

7.  Genotype-phenotype correspondence in Sanfilippo syndrome type B.

Authors:  H G Zhao; E L Aronovich; C B Whitley
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

8.  Identification and characterisation of mutations underlying Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB).

Authors:  G J Lee-Chen; S P Lin; S Z Lin; C K Chuang; K T Hsiao; C F Huang; W C Lien
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

9.  Sequence variations in the first exon of alpha-galactosidase A.

Authors:  J P Davies; B G Winchester; S Malcolm
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

10.  Sanfilippo B syndrome: molecular defects in Greek patients.

Authors:  C Beesley; M Moraitou; B Winchester; K Schulpis; E Dimitriou; H Michelakakis
Journal:  Clin Genet       Date:  2004-02       Impact factor: 4.438

View more
  14 in total

1.  Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease).

Authors:  J de Ruijter; L Broere; M F Mulder; A T van der Ploeg; M E Rubio-Gozalbo; S B Wortmann; G Visser; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2013-10-31       Impact factor: 4.982

2.  Adult-onset painful axonal polyneuropathy caused by a dominant NAGLU mutation.

Authors:  Martine Tétreault; Michael Gonzalez; Marie-Josée Dicaire; Pierre Allard; Kalle Gehring; Diane Leblanc; Nadine Leclerc; Ronald Schondorf; Jean Mathieu; Stephan Zuchner; Bernard Brais
Journal:  Brain       Date:  2015-03-28       Impact factor: 13.501

3.  Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype.

Authors:  Marlies J Valstar; Hennie T Bruggenwirth; Renske Olmer; Ron A Wevers; Frans W Verheijen; Ben J Poorthuis; Dicky J Halley; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-09-18       Impact factor: 4.982

4.  Structural and mechanistic insight into the basis of mucopolysaccharidosis IIIB.

Authors:  Elizabeth Ficko-Blean; Keith A Stubbs; Oksana Nemirovsky; David J Vocadlo; Alisdair B Boraston
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

5.  Treatment effect of coenzyme Q(10) and an antioxidant cocktail in fibroblasts of patients with Sanfilippo disease.

Authors:  Leslie Matalonga; Angela Arias; María Josep Coll; Judit Garcia-Villoria; Laura Gort; Antonia Ribes
Journal:  J Inherit Metab Dis       Date:  2013-12-18       Impact factor: 4.982

Review 6.  Sanfilippo syndrome: a mini-review.

Authors:  M J Valstar; G J G Ruijter; O P van Diggelen; B J Poorthuis; F A Wijburg
Journal:  J Inherit Metab Dis       Date:  2008-04-04       Impact factor: 4.982

7.  Genotype to Phenotype: Identification of Mucopolysaccharidosis Type IIIB (Sanfilippo's B) Case Using Whole Exome Sequencing.

Authors:  Muhsin Elmas; Basak Gogus; Furkan Kılıçarslan; Aysegul Bukulmez; Mustafa Solak
Journal:  J Pediatr Genet       Date:  2020-03-31

8.  Natural history of Sanfilippo syndrome in Spain.

Authors:  Verónica Delgadillo; Maria del Mar O'Callaghan; Laura Gort; Maria Josep Coll; Mercedes Pineda
Journal:  Orphanet J Rare Dis       Date:  2013-12-06       Impact factor: 4.123

9.  Temporospatial Development of Neuropathologic Findings in a Canine Model of Mucopolysaccharidosis IIIB.

Authors:  Tyler A Harm; Shannon J Hostetter; Ariel S Nenninger; Bethann N Valentine; N Matthew Ellinwood; Jodi D Smith
Journal:  Vet Pathol       Date:  2020-11-18       Impact factor: 2.221

10.  A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.

Authors:  Victor Mauri; Parisa Lotfi; Laura Segatori; Marco Sardiello
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.